Opinion|Videos|November 30, 2023

How HER2 Targeted Therapies Fight HER2-Positive Metastatic Breast Cancer

HER2-targeted therapies improve outcomes by shutting down growth signaling to cancer cells, targeted delivery of chemotherapy, or blocking intracellular signaling - all leveraging the HER2 receptor to better control metastatic breast cancer.

Newsletter

Stay up to date on cancer updates, research and education